Interstitial lung diseases associated with smoking

Česká verzia

Authors: Markéta Nová ¹; Helena Hornychová ¹; Radoslav Matěj ^2,3
Authors place of work: Fingerlandův ústav patologie, Fakultní nemocnice a Lékařská fakulta Karlovy univerzity, Hradec Králové ¹; Oddělení patologie a molekulární medicíny, Thomayerova nemocnice, Praha ²; Ústav patologie 1. LF UK a VFN, Praha ³
Published in the journal: Čes.-slov. Patol., 52, 2016, No. 2, p. 100-105
Category: Přehledové články - Interscitiální plicní procesy

Summary

There are many different interstitial lung diseases associated with smoking. This short review describes officially recognized disorders (desquamative interstitial pneumonia, respiratory bronchiolitis and pulmonary Langerhans´cells histiocytosis) and entities with uncertain relationship to smoking, which have recently been published in the literature. Histopathological pictures and differential diagnosis of smoking-related diseases of the lungs are discussed.

Keywords:
emphysema – pneumonia – bronchiolitis – smoking – fibrosis – histiocytosis

Zdroje

1. Prasse A, Stahl M, Schulz G et al. Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009; 174: 1683–1691.

2. Hasleton P, Flieder DB. Spencer‘s pathology of the lung (6th edn). Cambridge University Press: Cambridge; 2013: 385-390.

3. Travis WD, Costabel U, Hansell DM et al. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2013; 188: 733–748.

4. Flaherty K, Fell Ch, Aubry M et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J 2014; 44: 594–602.

5. Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin Chest Med 2012; 33: 165–178.

6. Margaritopoulos G, Vasarmidi E, Jacob J et al. Smoking and interstitial lung diseases. Eur Respir Rev 2015; 24: 428–435.

7. Jankowich MD, Rounds SI. Combined Pulmonary Fibrosis and Emphysema Syndrome: a review. Chest 2012; Jan 141(1): 222-231.

8. Hagmeyer L, Randerath W. Smoking-related interstitial lung disease. Dtsch Arztebl Int 2015; 112: 43–50.

9. Bruder E, Hofmeister J, Aslanidis C et al. Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation. Modern Pathology 2007; 20: 1009–1018.

10. Katzenstein AL, Mukhopadhyay S, Zanardi C et al. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010; 41(3): 316-325.

11. Kawabata Y, Hoshi E, Murai K et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707-714.

12. Katzenstein A. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Modern Pathology 2012; 25: 68–78.

13. Tazi A. Adult pulmonary Langerhans‘ cell histiocytosis. Eur Respir J 2006; 27: 1272-1285.

14. Suri HS, Yi ES, Nowakowski GS et al. Pulmonary langerhans cell histiocytosis.Orphanet Journal of Rare Diseases 2012; 7:16.

15. Cottin V, Nunes H, Brillet PY et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26(4): 586-593.

16. Cottin V, Le Pavec J, Prévot G et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105–111.

17. Wright J, Tazelaar H, Churg A. Fibrosis with emphysema. Histopathology 2011; 58: 517–524.